A Los Angeles entrepreneur may have quietly become the case study Sam Altman was talking about when he predicted AI would facilitate a one-person $1 billion business. In the New York Times, Erin Griffith profiles 41-year-old Matthew Gallagher, who used about $20,000 and a number of AI tools to launch MEDvi, a telehealth company that sells GLP-1 weight-loss drugs, from his home in 2024. AI wrote MEDvi’s code and marketing copy, generated its ads, ran customer service, and even analyzed its performance.
In its first year, MEDvi brought in $401 million in sales; this year, Gallagher and his sole full-time hire—his younger brother—are on pace for $1.8 billion in revenue. The Times, which reviewed MEDvi’s financials to confirm his numbers, reports the company’s net profit in 2025 was 16.2%. Gallagher doesn’t mess with the doctor- and prescription-side of things: Outside telehealth platforms CareValidate and OpenLoop Health supply doctors, pharmacies, and shipping, while AI agents glue it all together.
Griffith notes the earliest iteration of MEDvi had plenty of “AI slop”: “MEDvi’s initial website featured photos of smiling models who looked AI-generated and before-and-after weight-loss photos from around the web with the faces changed. … A scrolling ticker of mainstream media logos made it look as if MEDvi had been featured in Bloomberg and the Times when it had merely advertised there.” It was enough to get him 300 customers in month one. In February, he branched out into men’s medications, including those for erectile dysfunction—and had 50,000 customers in the first month. He’s brought on some contractors but has no plans to hire more employees, which he thinks would slow him down. But “at this point, I kind of want to hire people because I’m lonely.” Read the full story for much more.